Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ciliary activity refers to the rhythmic, coordinated beating of motile cilia, which are hair-like, microtubule-based organelles protruding from the apical surface of epithelial cells, most notably within the respiratory tract. This activity is the primary mechanical driver of mucociliary clearance (MCC), a vital innate defense mechanism that captures and transports inhaled pathogens, allergens, and debris out of the lungs [1, 3, 14]. The molecular engine of ciliary activity resides in the axoneme, a complex structure powered by dynein ATPase motors that facilitate microtubule sliding. Ciliary beat frequency (CBF) is tightly regulated by intracellular second messengers, including cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), and calcium ions (Ca²⁺) [5, 11]. In clinical conditions such as chronic obstructive pulmonary disease (COPD), asthma, and primary ciliary dyskinesia (PCD), ciliary activity is typically impaired or absent, leading to stagnant mucus, chronic inflammation, and recurrent respiratory infections [4, 7, 9]. Therapeutic strategies often focus on enhancing ciliary activity using cilio-excitatory agents like Beta-2 adrenergic agonists and phosphodiesterase (PDE) inhibitors, which increase cAMP levels to stimulate motor protein function [1, 5, 10]. Conversely, the preservation of ciliary activity is a major challenge in drug development, as many intranasal excipients and environmental toxins can exert cilio-inhibitory effects [8, 10].
Pharmacological modulation of ciliary activity occurs primarily through the cAMP-PKA and Ca2+-calmodulin signaling pathways. Beta-2 adrenergic agonists and PDE4 inhibitors increase intracellular cAMP, which activates protein kinase A (PKA) to phosphorylate axonemal dynein motors, thereby increasing the ciliary beat frequency [1, 5]. Purinergic agonists such as ATP and UTP bind to P2Y2 receptors, triggering a rise in intracellular calcium that similarly stimulates ciliary motion [14].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliary activity (CBF).